1:Thymosin alpha 1 combined with PD-1 antibody and Apatinib
Sponsors
Shanghai Dongfang Hospital
Conditions
Advanced Gastric Cancer
Early Phase 1
Efficacy and safety of Thymosin alpha 1 combined with anti-PD-1 and Apatinib in advanced gastric cancer patients failed to second line treatment
Active, not recruitingITMCTR1900002540
Start: 2019-08-21Updated: 2023-02-20
Efficacy and safety of Thymosin alpha 1 combined with anti-PD-1 and Apatinib in advanced gastric cancer patients failed to second line treatment
Active, not recruitingChiCTR1900025367
Start: 2019-08-21Updated: 2019-08-27